ClinicalTrials.gg
RecruitingNCT07323875STRIDEUpdated Oct 13, 2026

Single-Row Versus Double-Row Repair for Achilles Insertional Tendinopathy

An interventional study of Single-row repair of the Achilles tendon at its calcaneal insertion and Double-row repair of the Achilles tendon at its calcaneal insertion in Achilles Insertional Tendinopathy and Achilles Tendinopathy, sponsored by Women's College Hospital. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by Women's College Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Aug 2026; still recruiting 3 months later.
Updated Oct 13, 2026Now RecruitingSite recruiting status changed+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
166
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 17 studies in Tendinopathy with a site in Canada — 3 open to participants now, 3 under way, none of them phase 3. Tendinopathy · Canada.

Planned enrollment
2nd of 14
166 · median 51
Started
2026
the only one that year
No phase
9 of 17
2 open now
Registered
17th of 17
by date

Among the 17 studies in Tendinopathy with a site in Canada, this one is the 2nd largest by planned enrollment of the 14 interventional ones that give a count, is the only one that started in 2026, is one of 9 with no phase, and was the 17th registered.

Tendinopathy

399 studies on the registry are indexed under Tendinopathy; 77 are open to participants now.

Browse Tendinopathy studies →

Open to participants now

3 of the 17 studies in Tendinopathy with a site in Canada are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 46 Tendinopathy studies recruiting now, 17 (37%) set no upper age limit and 22 (48%) stop at 75 or younger; 1 takes children under 18; 7 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 17 studies in Tendinopathy with a site in Canada, or all of them as a file.
02

Study summary

Achilles insertional tendinopathy may require surgical debridement and tendon reattachment when non-operative treatment fails. Single-row and double-row repairs are used, with biomechanical studies favoring double-row, but clinical evidence of improved outcomes is lacking and costs are higher. This multi-center randomized trial will use the VISA-A score to compare outcomes and inform cost-effective, evidence-based surgical care.

Read the detailed description

Double-row repairs for Achilles insertional tendinopathy have been shown biomechanically to be stronger than single-row repairs, but clinical studies have not demonstrated clear advantages. Existing comparative studies are limited by retrospective designs and use of non-validated outcome measures such as AOFAS, VAS, and SF-36 Physical Function. No prospective randomized trials have evaluated clinical outcomes of single-row versus double-row repairs.

This multi-center randomized controlled trial will use the disease-specific Victorian Institute of Sports Assessment-Achilles (VISA-A) score to compare clinical outcomes between single-row and double-row repairs, providing high-quality evidence to guide optimal surgical management.

03

Conditions studied

  • Achilles Insertional Tendinopathy
  • Achilles Tendinopathy

Browse trials for

Keywords

  • single row repair
  • double row repair
  • calcaneal insertion
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Must be deemed to have capacity to provide ;
  2. Must sign and date the informed consent form;
  3. Stated willingness to comply with all study procedures;
  4. Adult patients between the ages of 18 and 75 years with symptomatic chronic Achilles insertional tendinopathy for a minimum of 3 months
  5. Failure of non-operative management (which includes physiotherapy, stretching exercises, heel lifts, nonsteroidal anti-inflammatory drugs (NSAIDs), activity modification, etc.) for at least 3 months.
  6. Preoperative imaging (x-ray and Medical Resonance Imaging (MRI)) is available and completed;
  7. Willingness of patients to follow the postoperative rehabilitation protocol;
  8. Willingness of patients to be available for follow up appointments for up to 2 years.

Exclusion criteria

Exclusion Criteria:

  1. Non-insertional Achilles tendinopathy;
  2. Achilles tendon rupture;
  3. Previous Achilles tendon surgery;
  4. Oral use or steroid injection within 3 months of surgery;
  5. History of connective tissue or collagen disorder (e.g. Marfan Syndrome)
  6. History of chronic inflammatory disorders
  7. History of neurological disease (stroke, cerebral palsy)
  8. History of using more than 30mg of oxycodone or equivalent per day;
  9. Current cigarette smoker (Former smokers must have quit for minimum of one year)
  10. Diabetes type I or II
  11. Pregnancy
  12. to metal, Polylactic Acid (PLA), or Polyetheretherketone (PEEK) materials
  13. Active infection
  14. Worker's compensation claim (e.g. WSIB)
  15. History of cognitive or mental health conditions that would make the participant unable to complete study procedures
  16. Non-English speaking
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
166 participants (estimated)

Study arms

  • Active comparator
    Single-row repair Arm

    Single-row repair will involve 2 suture anchors (2 anchors total)

    Procedure: Single-row repair of the Achilles tendon at its calcaneal insertion

  • Active comparator
    Double-row repair Arm

    Double-row repair will involve 2 suture anchors for the proximal row and 2 suture anchors for the distal row (4 anchors total)

    Procedure: Double-row repair of the Achilles tendon at its calcaneal insertion

Interventions

  • ProcedureSingle-row repair of the Achilles tendon at its calcaneal insertion

    single-row (2 anchors)

  • ProcedureDouble-row repair of the Achilles tendon at its calcaneal insertion

    double-row (4 anchors)

06

What researchers measure

Primary outcomes

  1. Disease-specific outcomes

    The Victorian Institute of Sport Assessment-Achilles (VISA-A) questionnaire is a validated, self-reported outcome measure designed to assess the severity of Achilles tendinopathy. It evaluates three key domains: pain, function, and activity level and produces a score from 0 to 100, with higher scores indicating better function and fewer symptoms.

    Time frame: 24 months after surgery

Secondary outcomes

  1. Surgical Cost

    Assess the cost difference between single-row repair versus double-row repair

    Time frame: Within 2 hours of surgery

  2. Foot and Ankle Ability Measure (FAAM)

    The FAAM is a patient-reported outcome questionnaire designed to assess physical function in individuals with foot and ankle disorders. Scores are typically expressed as percentages, with higher scores indicating better function.

    Time frame: 24 months after surgery

  3. Visual Analogue Scale Foot and ankle (VAS-FA)

    The VAS-FA is a patient-reported outcome measure designed to assess pain, function, and other symptoms related to foot and ankle disorders. It uses a visual analogue scale, typically a 100 mm line, where patients indicate the severity of their symptoms. Higher scores usually indicate better function or less pain.

    Time frame: 24 months after surgery

  4. Plantarflexion strength

    Measured using a HUMAC Norm Isokinetic Dynamometer Weakness: May indicate calf muscle atrophy, nerve injury, or Achilles tendon dysfunction. Deficits: Can cause altered gait, decreased push-off, and balance problems.

    Time frame: 24 months after surgery

  5. Biomechanical performance

    Including ankle kinematics and kinetics during gait and functional tasks, assessed through markerless motion tracking. Gait Analysis: Evaluating walking or running patterns in patients with musculoskeletal or neurological impairments.

    Time frame: 24 months after surgery

  6. Functional endurance

    As measured by the Heel Rise Test Normal: Able to perform ≥25-30 single-leg heel raises with minimal fatigue. Weakness: Fewer repetitions or lower heel height may suggest calf muscle weakness.

    Time frame: 24 months after surgery

  7. Surgical Time

    Assess the operative time required for single-row repair versus double-row repair.

    Time frame: During surgery

  8. TENDINopathy Severity Assessment - Achilles (TENDINS-A)

    A validated patient-reported outcome measure assessing pain, symptoms, and functional limitations associated with Achilles tendinopathy. Higher scores indicate greater disability and symptom severity.

    Time frame: 24 months after surgery

07

Study locations

1 of 1 sites recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2026 (actual). Primary completion is estimated for Aug 2028, 24 months after the start.

Of 174 non-industry interventional studies with no phase under Tendinopathy, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 38. This study's planned 24 months is above that.

Counting every sponsor, half of 183 studies reached it within 20 months; a quarter within 7 and three quarters within 37.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 13, 2026: start Sep 2026 → Aug 2026, primary completion Feb 2028 → Aug 2028 and completion Mar 2030 → Aug 2030.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Nov 28, 2025
First posted
Jan 7, 2026
StartActual
Aug 12, 2026was Sep 2026
Primary completionEst.
Aug 2028was Feb 2028
CompletionEst.
Aug 2030was Mar 2030
Last update
Oct 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 13, 2026
Sites
Women's College Hospital is now Recruiting
Oct 13, 2026
Start date
Sep 2026→Aug 12, 2026 (actual)
Oct 13, 2026
Primary completion
Feb 2028→Aug 2028
Oct 13, 2026
Study completion
Mar 2030→Aug 2030
Oct 13, 2026
Eligibility
Maximum age 75 Years→none
Oct 13, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Women's College Hospital · Toronto, CanadaContact added d•••@wchospital.ca · •••6008
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    Not yet recruiting→Recruiting
    Women's College Hospital is now Recruiting
    Start date Sep 2026→Aug 12, 2026 (now actual)
    Primary completion Feb 2028→Aug 2028
    Study completion Mar 2030→Aug 2030
    Eligibility Maximum age 75 Years→none
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Women's College Hospital · Toronto, CanadaContact added d•••@wchospital.ca · •••6008
    + 2 other changes: identifiers and verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07323875
Lead sponsor
Women's College Hospital
Collaborators
The Physicians' Services Incorporated Foundation, University Health Network, Toronto, Unity Health Toronto, University of Toronto
Responsible party
Sponsor
First posted
Jan 7, 2026
Start date
Aug 12, 2026
Primary completion
Aug 2028 (estimated)
Completion
Aug 2030 (estimated)
Last update
Oct 13, 2026

Study contacts

Didem Bozak
Contact
didem.bozak@wchospital.ca
6473814051
Si-Hyeong Sam Park, MD, FRCPC
principal investigator · Women's College Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion